Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Sertraline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for sertraline hydrochloride and what is the scope of sertraline hydrochloride freedom to operate?

Sertraline hydrochloride
is the generic ingredient in two branded drugs marketed by Wockhardt, Aurobindo Pharma, Zydus Pharms Usa, Sun Pharm Inds (in), Sandoz, Frontida Biopharm, Ivax Sub Teva Pharms, Accord Hlthcare, Mylan Pharms Inc, Allied Pharma Inc, Pfizer, Dr Reddys Labs Ltd, Actavis Elizabeth, Ranbaxy Labs Ltd, Cipla Ltd, Watson Labs, Hikma Pharms, Teva, Torrent Pharms, Lupin, Mylan, Oxford Pharms, Austarpharma Llc, Sun Pharm Inds Ltd, Apotex Inc, Invagen Pharms, and Pliva Hrvatska Doo, and is included in thirty-one NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Sertraline hydrochloride has forty-eight patent family members in forty-five countries.

There are twenty-two drug master file entries for sertraline hydrochloride. Sixty-two suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: sertraline hydrochloride

Tradenames:2
Patents:3
Applicants:27
NDAs:31
Drug Master File Entries: see list22
Suppliers / Packagers: see list62
Bulk Api Vendors: see list68
Clinical Trials: see list1,090
Therapeutic Class:Anxiolytics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sertraline hydrochloride at DailyMed

Pharmacology for Ingredient: sertraline hydrochloride

Tentative approvals for SERTRALINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 25MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 100MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 50MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
ZOLOFT
sertraline hydrochloride
CONCENTRATE;ORAL020990-001Dec 7, 1999AARXYesYes7,067,555*PED► SubscribeY► Subscribe
Sun Pharm Inds (in)
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL078108-003Feb 6, 2007ABRXNoNo► Subscribe► Subscribe
Frontida Biopharm
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL077818-001Feb 6, 2007DISCNNoNo► Subscribe► Subscribe
Watson Labs
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL077663-002Feb 6, 2007DISCNNoNo► Subscribe► Subscribe
Apotex Inc
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL076882-003Feb 6, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot